| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 06/04/2008 | EP1560893A4 Photochromic compositions and light transmissible articles |
| 06/04/2008 | CN101193896A Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors |
| 06/03/2008 | US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 06/03/2008 | US7381585 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 06/03/2008 | US7381546 Immunosuppressant selected from prolyl-rapamycin, 4-hydroxy-prolyl-rapamycin, 4-hydroxyprolyl-26-demethoxy-rapamycin, 3-hydroxy-prolyl-rapamycin, 3-hydroxy-prolyl-26-demethoxy-rapamycin, and trans-3-aza-bicyclo[3,1,0]hexane-2-carboxylic acid rapamycin |
| 06/03/2008 | CA2175215C Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| 05/29/2008 | WO2008064274A1 Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| 05/29/2008 | WO2008064061A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 05/29/2008 | WO2008064057A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 05/29/2008 | WO2008063668A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008063287A2 Novel imidazothiazoles and imidazoxazoles |
| 05/29/2008 | US20080125457 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 05/29/2008 | US20080125452 Indolopyridines,Benzofuranopyridines and Benzothienopyridines |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125422 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 05/29/2008 | CA2673137A1 Prodrug salts of 2,4-pyrimidinediamine compounds and their uses |
| 05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2668369A1 5-hydroxymethyl-oxazolidin-2-one antibacterials |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1924579A2 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 05/28/2008 | EP1781644B1 Macrocyclic beta-secretase inhibitors |
| 05/28/2008 | CN101189222A Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 05/28/2008 | CN101186613A Cytotoxic agents comprising new maytansinoids |
| 05/28/2008 | CN100390160C Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor |
| 05/27/2008 | CA2514473C Fused bicyclic nitrogen-containing heterocycles |
| 05/22/2008 | WO2008060248A1 Indole sustituted pyrimidines and use thereof in the treatment of cancer |
| 05/22/2008 | WO2008059238A1 Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer |
| 05/22/2008 | WO2008022024A3 Imidazole amines as inhibitors of beta-secretase |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119478 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria |
| 05/21/2008 | EP1922311A2 Acyclic ikur inhibitors |
| 05/21/2008 | EP1603557A4 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 05/21/2008 | EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 05/21/2008 | DE102007053198A1 Photoinitiatoren für strahlungshärtbare Beschichtungsmassen Photoinitiators for radiation-curable coating compositions |
| 05/21/2008 | CN101184761A Spiro-oxindole compounds and their uses as therapeutic agents |
| 05/21/2008 | CN100389115C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375217 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | CA2453123C Intermediate for condensed benzazepine derivatives |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2205664C Indole derivatives and medicinal use thereof |
| 05/15/2008 | WO2008057875A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057873A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057871A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057511A2 Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 05/15/2008 | WO2008057209A1 Hcv ns3 protease inhibitors |
| 05/15/2008 | WO2008056372A1 A pure form of rapamycin and a process for recovery and purification thereof |
| 05/15/2008 | US20080114166 Printing inks for digital textile printing; reactivity, fixability, build up; light and perspiration fastness; synthesis step |
| 05/15/2008 | US20080113966 CGRP (Calcitonin Gene-Related Peptide); migraine and cluster headache; compounds based on 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine or 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine |
| 05/15/2008 | US20080112033 Reversible recording material and displaying element |
| 05/15/2008 | CA2669714A1 A pure form of rapamycin and a process for recovery and purification thereof |
| 05/15/2008 | CA2668134A1 Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| 05/15/2008 | CA2667031A1 Hcv ns3 protease inhibitors |
| 05/14/2008 | EP1919922A1 Method for synthesizing spiro quaternary ammonium systems |
| 05/14/2008 | CN101180054A Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 05/13/2008 | US7371875 Compounds based on 3,7-dioxo-2-aza-6-oxabicyclo(3.2.0)heptane; proteosome inhibitors for treating proliferative or inflammatory disorders with better stability, toxicity and/or oral bioavailability |
| 05/13/2008 | US7371864 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one for treating thromboembolic disorders |
| 05/13/2008 | US7371863 Method for manufacture of THIP |
| 05/13/2008 | US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O |
| 05/13/2008 | US7371771 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase |
| 05/13/2008 | CA2196995C Spiro-azabicyclic compounds useful in therapy |
| 05/08/2008 | WO2008054288A1 8-sulfonyl-l, 3, 4, 8-tetrahydr0-2h- [1, 4] oxazepino [6, 7-e] indole derivatives and their use as 5-ht6 receptor ligands |
| 05/08/2008 | WO2008039359A3 Bicyclic pyrimidine kinase inhibitors |
| 05/08/2008 | WO2007117591A3 Total synthesis of salinosporamide a and analogs thereof |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | CA2667857A1 8-sulfonyl-1, 3, 4, 8-tetrahydr0-2h- [1, 4] oxazepino [6, 7-e] indole derivatives and their use as 5-ht6 receptor ligands |
| 05/07/2008 | EP1917269A2 Inhibitors of serine proteases |
| 05/07/2008 | EP1917268A2 Preparation of 2,6-dioxa-7-aza-bicyclo(2.2.2)octanes, and their use in coatings |
| 05/07/2008 | EP1280807B1 Photochromatic pyrano-1,3-oxazinonaphthalene derivatives |
| 05/07/2008 | EP1097135B1 Process for the preparation of an indole derivative |
| 05/07/2008 | CN101175760A 39-desmethoxy derivatives of rapamycin |
| 05/07/2008 | CN101175756A Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172981A 2,3-dihydroimidazo[2,1-b]oxazole compound |
| 05/06/2008 | US7368567 Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists |
| 05/06/2008 | US7368565 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 05/06/2008 | US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 05/02/2008 | WO2008051763A1 Cathepsin proteases inhibitors |
| 05/02/2008 | WO2008051493A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 05/02/2008 | WO2008028934A8 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 05/02/2008 | CA2667816A1 Compositions and methods for inhibiting cathepsin proteases |
| 05/02/2008 | CA2666618A1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 05/01/2008 | US20080103188 Novel bicyclic compounds as modulators of androgen receptor function |
| 05/01/2008 | US20080103161 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/01/2008 | US20080103151 Heterocyclic compounds and their uses as therapeutic agents |
| 04/30/2008 | EP1915380A1 Process for the preparation of n,n´- disubstituted oxabispidines |
| 04/30/2008 | EP1915379A1 Olanzapine analogs and methods of use thereof |
| 04/30/2008 | EP1335725B1 Use of cci-779 as an antineoplastic agent |
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/30/2008 | CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |